Invitation to Bid - Lignocaine and ethanol spray,Atropine sulphate injection,Deflazacort Tab,Paracetamol infusion,Tab N in RANCHI, JHARKHAND

The eligibility requirements for suppliers include being a legally registered entity capable of providing pharmaceuticals. Suppliers must demonstrate that they are compliant with relevant pharmaceutical regulations and hold valid licenses for the distribution of the specified medications. Additionally, bidders are expected to provide evidence of prior experience in a similar supply capacity, ideally covering comparable volumes and pharmaceutical categories. This ensures that participating vendors are capable of delivering the required pharmaceutical range in a timely and reliable manner.

The technical specifications require that all pharmaceuticals supplied align with the World Health Organization’s standards and are compliant with local health regulations. Suppliers must furnish detailed product documentation, such as data sheets and compliance certificates, to verify that each item meets the stipulated quality and safety parameters. Moreover, adherence to guidelines outlined by health authorities is critical to ensure the integrity and efficacy of the pharmaceuticals delivered.

Yes, bidders may be required to provide an Earnest Money Deposit (EMD) alongside their submissions. The EMD serves as a security measure to ensure that bidders are committed and will adhere to the terms of the tender. Furthermore, successful bidders might also need to submit performance security as part of their contract obligations. It is important to refer to tender documents for specific details regarding monetary requirements and acceptable forms of security.

The evaluation and selection process for this tender will follow an item-wise approach where submissions will be assessed based on adherence to the technical and financial specifications laid out within the tender documents. Factors such as the reliability of past deliveries, compliance with technical requirements, and overall cost effectiveness will play significant roles in determining the successful bidders. Vendors will be notified in writing regarding the outcomes of their submissions after the evaluation is completed.

MSEs responding to this tender are entitled to special provisions that aim to promote inclusivity and support smaller businesses in the pharmaceutical supply chain. These provisions may include favorable evaluation criteria to encourage MSE participation. Additionally, vendors can request the necessary documentation that underscores their MSE status to ensure compliance with these supportive measures. Engaging in this tender provides MSEs a meaningful opportunity to contribute to public health while growing their businesses in a competitive arena.